Cell state plasticity, stem cells, EMT, and the generation of intra-tumoral heterogeneity
Abstract Cellular heterogeneity in cancer represents a significant challenge. In order to develop effective and lasting therapies, it is essential to understand the source of this heterogeneity, and its role in tumor progression and therapy resistance. Here, we consider not only genetic and epigenet...
Main Authors: | Geoffrey M. Wahl, Benjamin T. Spike |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2017-04-01
|
Series: | npj Breast Cancer |
Online Access: | https://doi.org/10.1038/s41523-017-0012-z |
Similar Items
-
Inflammation-Driven Breast Tumor Cell Plasticity: Stemness/EMT, Therapy Resistance and Dormancy
by: Tamir Baram, et al.
Published: (2021-01-01) -
Lgr5 is a marker for fetal mammary stem cells, but is not essential for stem cell activity or tumorigenesis
by: Christy L. Trejo, et al.
Published: (2017-04-01) -
Stem Cell Theory of Cancer: Origin of Tumor Heterogeneity and Plasticity
by: Shi-Ming Tu, et al.
Published: (2021-08-01) -
Plasticity between Epithelial and Mesenchymal States Unlinks EMT from Metastasis-Enhancing Stem Cell Capacity
by: Evelyne Beerling, et al.
Published: (2016-03-01) -
Impact of the Tumor Microenvironment on Tumor Heterogeneity and Consequences for Cancer Cell Plasticity and Stemness
by: Ralf Hass, et al.
Published: (2020-12-01)